New Solution for Cancer Therapy from Siemens

Siemens HealthcareOne of Siemens Healthcare's highlights of this year's Conference of the European Society for Therapeutic Radiology and Oncology (ESTRO) is IM-RealART™ Solution for adaptive radiotherapy. With IM-RealART, treatment plans for radiotherapy can be adapted especially fast to changes in the shape and position of tumors. The treatment plan is revised even while the patient is still lying on the treatment table. This means that the radiation fields and dose are recalculated directly before the next fraction is irradiated.

With IM-RealART, Siemens Healthcare offers a new solution for especially fast replanning of treatment plans in adaptive radiotherapy. The solution includes the Siemens products Artiste™ Solution (linear accelerator), the 550TxT™ treatment table, the CTVision™ System for diagnostic CT (computed tomography) imaging and the RealART™ planning system from Prowess Inc.

One of the special advantages of IM-RealART is CTVision. Using this system, top quality "gold standard" images of tumors can be taken directly in the treatment room using a CT scanner running on rails. While the patient lies immobilized on the treatment table, the current scans are compared to the original ones on which the treatment planning was based and evaluated.

If the shape of the tumor has changed, the treatment plan can be adapted immediately in order to correct the shape of the treatment radiation field as well as the dose. This recalculation is usually performed in just seven minutes. Since the patient's position is not changed during this period, it is possible to irradiate the tumor with high precision. Using the 160MLC™ multileaf collimator from Siemens, the radiation field can be confined to the tumor very precisely, thus saving the surrounding tissue.

IM-RealART can be combined with the Siemens solution IM-Confident™ Plan, which consists of Artiste with the 160MLC and an intelligent irradiation planning software. These components help reduce the treatment time required for intensity-modulated radiation therapy (IMRT) to five minutes or even less.

IM-RealART and IM-Confident from Siemens offer two solutions which, on the one hand, make daily workflows in radiooncology much simpler and more efficient while, at the same time, enabling high precision patient treatment: Using innovative technologies, the tumor is irradiated with pinpoint accuracy while the latest software and imaging ensure that planning, replanning and therapy all proceed as swiftly as possible. This corresponds to Siemens' philosophy for radiotherapy: To achieve rapid and precise treatment while sparing the patient undue discomfort.

Related news articles:

About Siemens Healthcare Sector
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros. For further information please visit: www.siemens.com/healthcare.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...